Education
About Us
Working with TipRanks
Follow Us
Evolent Health (EVH)
NYSE:EVH
Total Valuation
Evolent Health has a market cap or net worth of $353.89M. The enterprise value is $1.19B.
Market Cap$353.89M
Enterprise Value$1.19B
Share Statistics
Evolent Health has 111,638,336 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding111,638,336
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Evolent Health’s return on equity (ROE) is -1.29 and return on invested capital (ROIC) is -0.29%.
Return on Equity (ROE)-1.29
Return on Assets (ROA)-0.28
Return on Invested Capital (ROIC)-0.29%
Return on Capital Employed (ROCE)>-0.01
Revenue Per Employee416.94K
Profits Per Employee-128.76K
Employee Count4,500
Asset Turnover0.99
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Evolent Health is ―. Evolent Health’s PEG ratio is -0.00163.
PE Ratio―
PS Ratio0.24
PB Ratio1.10
Price to Fair Value1.10
Price to FCF96.07
Price to Operating Cash Flow9.32
PEG Ratio-0.00163
Income Statement
In the last 12 months, Evolent Health had revenue of 1.88B and earned -534.51M in profits. Earnings per share was -5.07.
Revenue1.88B
Gross Profit283.03M
Operating Income-4.43M
Pretax Income-534.64M
Net Income-534.51M
EBITDA-361.31M
Earnings Per Share (EPS)-5.07
Cash Flow
In the last 12 months, operating cash flow was 38.84M and capital expenditures -34.09M, giving a free cash flow of 4.75M billion.
Operating Cash Flow38.84M
Free Cash Flow4.75M
Free Cash Flow per Share0.04
Dividends & Yields
Evolent Health pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta>-0.01
52-Week Price Change-65.16%
50-Day Moving Average3.46
200-Day Moving Average6.85
Relative Strength Index (RSI)48.50
Average Volume (3m)3.34M
Important Dates
Evolent Health upcoming earnings date is May 6, 2026, After Close (Confirmed).
Last Earnings DateFeb 24, 2026
Next Earnings DateMay 6, 2026
Ex-Dividend Date―
Financial Position
Evolent Health as a current ratio of 1.31, with Debt / Equity ratio of 238.37%
Current Ratio1.31
Quick Ratio1.31
Debt to Market Cap2.16
Net Debt to EBITDA-2.32
Interest Coverage Ratio-0.08
Taxes
In the past 12 months, Evolent Health has paid -126.00K in taxes.
Income Tax-126.00K
Effective Tax Rate<0.01
Enterprise Valuation
Evolent Health EV to EBITDA ratio is -3.58, with an EV/FCF ratio of 272.28.
EV to Sales0.69
EV to EBITDA-3.58
EV to Free Cash Flow272.28
EV to Operating Cash Flow33.33
Balance Sheet
Evolent Health has $151.86M in cash and marketable securities with $989.70M in debt, giving a net cash position of -$837.84M billion.
Cash & Marketable Securities$151.86M
Total Debt$989.70M
Net Cash-$837.84M
Net Cash Per Share-$7.50
Tangible Book Value Per Share-$7.57
Margins
Gross margin is 15.09%, with operating margin of -0.24%, and net profit margin of -28.49%.
Gross Margin15.09%
Operating Margin-0.24%
Pretax Margin-28.50%
Net Profit Margin-28.49%
EBITDA Margin-19.26%
EBIT Margin-25.43%
Analyst Forecast
The average price target for Evolent Health is $5.58, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$5.58
Price Target Upside76.03% Upside
Analyst ConsensusStrong Buy
Analyst Count15
Revenue Growth Forecast-16.65%
EPS Growth Forecast-71.92%